Welltower Inc. (WELL) reported earnings on April 28, 2026, with mixed signals for the healthcare real estate investment trust. The company trades at $209.45 per share with a market cap of $146.14 billion. WELL operates as an S&P 500 REIT focused on seniors housing, post-acute care, and outpatient medical properties across the United States, Canada, and the United Kingdom. Meyka AI rates WELL with a grade of B+. The stock has gained 45.8% over the past year, though recent trading shows modest weakness. Investors are watching closely to see if the healthcare real estate sector continues its strong momentum.
WELL Earnings Results: The Numbers Behind the Report
Welltower’s latest earnings report reveals important trends in the healthcare real estate sector. The company continues to demonstrate solid operational performance across its diversified portfolio.
EPS and Revenue Performance
Welltower reported earnings per share of $1.45 for the most recent quarter, beating the estimate of $1.44 by $0.01. Revenue came in at $3.25 billion, exceeding the estimate of $3.09 billion by $155.6 million. This marks the second consecutive quarter of revenue outperformance, showing consistent execution. The EPS beat, though modest, reflects the company’s ability to manage costs effectively in a challenging interest rate environment.
Quarterly Trend Analysis
Looking at the past four quarters, WELL has shown improving momentum. In Q3 2025, the company reported EPS of $1.28 against an estimate of $1.22, beating by $0.06. Revenue was $2.52 billion versus $2.72 billion estimated, missing by $204 million. The most recent quarter’s revenue beat reverses that trend. Q2 2025 showed EPS of $1.20 against $1.15 estimated, with revenue of $2.39 billion versus $2.52 billion estimated. This pattern suggests improving operational efficiency.
Stock Performance and Market Reaction
WELL’s stock price reflects investor sentiment about the healthcare REIT sector and broader economic conditions. Current trading levels show both strength and caution in the market.
Current Price Action
Welltower trades at $209.45, down 0.51% on the day but up significantly over longer timeframes. The stock has climbed 45.8% over the past year and 12.84% year-to-date. The 52-week range spans from $141.55 to $216.43, showing substantial volatility. Daily volume of 2.01 million shares runs below the 3.15 million average, suggesting moderate trading interest around earnings.
Technical and Valuation Metrics
The stock trades at a P/E ratio of 147.5x, which appears elevated but reflects REIT accounting standards where earnings don’t capture full economic performance. The price-to-book ratio of 3.42x indicates investors value the company’s real estate assets significantly above book value. Analyst consensus remains strong with 24 buy ratings and 1 strong buy, showing broad support for the stock despite valuation concerns.
Healthcare REIT Sector Dynamics and WELL’s Position
Welltower operates in a sector benefiting from demographic tailwinds and structural healthcare trends. The company’s diversified portfolio positions it well for long-term growth.
Business Model and Portfolio Strength
Welltower invests in seniors housing, post-acute care facilities, and outpatient medical properties. The company’s focus on high-growth markets across three countries provides geographic diversification. With 697.75 million shares outstanding, the company maintains a substantial equity base. The dividend yield of 0.71% provides income to shareholders, though the payout ratio of 2.0x suggests the company reinvests significant earnings into growth.
Growth Metrics and Future Outlook
Operating cash flow per share reached $4.18, while free cash flow per share stands at $4.13. These metrics demonstrate the company’s ability to generate cash from operations. Revenue growth of 21.2% year-over-year shows strong expansion. Net income growth of 179.8% reflects improved profitability, though this includes one-time items. The company’s three-year revenue growth per share of 17.5% indicates consistent expansion in its core business.
What WELL’s Results Mean for Investors
The earnings report provides clarity on Welltower’s operational trajectory and investment appeal. Several factors shape the investment thesis going forward.
Earnings Quality and Sustainability
Welltower’s ability to beat revenue estimates for two consecutive quarters suggests improving operational execution. The modest EPS beat indicates the company manages its cost structure effectively despite inflationary pressures. Cash flow metrics remain healthy, with operating cash flow covering dividends comfortably. The company’s focus on high-quality real estate assets in growing markets supports long-term value creation.
Investment Considerations
Meyka AI rates WELL with a B+ grade, reflecting solid fundamentals with some valuation concerns. The high P/E ratio warrants caution for value-focused investors, though the company’s growth trajectory justifies premium pricing. The strong analyst consensus of 24 buy ratings provides confidence in the investment case. Investors should monitor interest rate trends, as REITs are sensitive to borrowing costs. The company’s diversified geographic footprint and focus on essential healthcare services provide defensive characteristics in economic downturns.
Final Thoughts
Welltower delivered strong Q1 2026 results with EPS of $1.45 and $3.25 billion revenue, both beating expectations. The company’s two-quarter revenue outperformance streak shows improving operational execution in healthcare REITs. With a $146.14 billion market cap and solid analyst backing, Welltower offers good healthcare real estate exposure. Meyka AI’s B+ grade reflects solid fundamentals, though high valuation multiples require caution. The 45.8% annual stock gain reflects investor confidence in demographic trends supporting seniors housing and post-acute care growth.
FAQs
Did Welltower beat or miss earnings estimates?
Welltower beat both metrics. EPS came in at $1.45 versus $1.44 estimated, beating by $0.01. Revenue was $3.25 billion versus $3.09 billion estimated, beating by $155.6 million. This marks the second consecutive quarter of revenue outperformance.
How does WELL’s latest quarter compare to previous quarters?
WELL shows improving momentum. Q3 2025 had EPS of $1.28 (beat by $0.06) but revenue missed. Q2 2025 showed EPS beat of $0.05 but revenue miss. The current quarter’s revenue beat reverses recent trends, suggesting strengthening operational execution.
What is Welltower’s current stock price and market cap?
WELL trades at $209.45 per share with a market cap of $146.14 billion. The stock is down 0.51% today but up 45.8% over the past year and 12.84% year-to-date, showing strong long-term performance.
What is Meyka AI’s rating for WELL?
Meyka AI rates WELL with a grade of B+, reflecting solid fundamentals with some valuation concerns. The company scores well on growth metrics and cash flow generation but trades at elevated multiples relative to historical averages.
What do analysts think about Welltower?
Analyst consensus is strongly bullish with 24 buy ratings and 1 strong buy rating. No sell ratings exist, indicating broad support for the stock. This consensus reflects confidence in the healthcare REIT sector’s long-term growth prospects.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)